STOCK TITAN

Guardian Pharmacy (NASDAQ: GRDN) director converts 1.3M Class B shares to Class A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. director and officer Fred Burke exercised a derivative position to acquire 1,298,826 shares of Class A common stock in an automatic conversion. On March 28, 2026, 1,298,826 shares of Class B common stock converted into an equal number of Class A shares at a stated price of $0.00 per share, pursuant to the company’s Amended and Restated Certificate of Incorporation. Following the transactions, Burke held 1,298,825 shares of Class B common stock and 2,139,239 shares of Class A common stock directly.

Positive

  • None.

Negative

  • None.
Insider Burke Fred
Role See Remarks
Type Security Shares Price Value
Exercise Class B Common Stock 1,298,826 $0.00 --
Exercise Class A Common Stock 1,298,826 $0.00 --
Holdings After Transaction: Class B Common Stock — 1,298,825 shares (Direct); Class A Common Stock — 2,139,239 shares (Direct)
Footnotes (1)
  1. [object Object]
Class B shares converted 1,298,826 shares Automatic conversion on March 28, 2026
Conversion price $0.00 per share Stated transaction price for Class B to Class A
Class A shares acquired 1,298,826 shares Received via derivative exercise/conversion
Class A shares after transaction 2,139,239 shares Direct Class A holdings following conversion
Class B shares after transaction 1,298,825 shares Direct Class B holdings following conversion
Derivative exercise count 1 transaction Exercise or conversion of derivative security
Class B common stock financial
"The Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Class A common stock financial
"automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion for the Class B to Class A conversion"
Amended and Restated Certificate of Incorporation regulatory
"Pursuant to Guardian Pharmacy Services, Inc.'s Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
automatic conversion financial
"shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burke Fred

(Last)(First)(Middle)
300 GALLERIA PARKWAY SE, SUITE 800

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock03/28/2026M1,298,826A(1)2,139,239D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock(1)03/28/2026M1,298,826 (1) (1)Class A Common Stock1,298,826(1)1,298,825D
Explanation of Responses:
1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.
Remarks:
President and Chief Executive Officer
/s/ Douglas Towns, Attorney-in-Fact03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GRDN director Fred Burke report?

Fred Burke reported an automatic conversion of 1,298,826 shares of Class B common stock into 1,298,826 shares of Class A common stock. The transaction was recorded at a stated price of $0.00 per share as a derivative exercise/conversion.

How many GRDN Class A shares does Fred Burke hold after this Form 4?

After the reported transaction, Fred Burke directly holds 2,139,239 shares of Class A common stock. This reflects the addition of 1,298,826 Class A shares from the automatic conversion of his Class B common stock position on March 28, 2026.

What happened to Fred Burke’s GRDN Class B common stock in this filing?

On March 28, 2026, 1,298,826 shares of Class B common stock automatically converted into Class A shares. After this conversion, Burke directly held 1,298,825 shares of Class B common stock according to the reported totals following the transaction.

Was the GRDN insider transaction an open-market purchase or sale?

The reported GRDN insider activity was a derivative exercise/conversion, not an open-market trade. Class B shares automatically converted into Class A shares under the company’s charter, at a stated transaction price of $0.00 per share, with no sale recorded.

What does the GRDN footnote say about the Class B to Class A conversion?

The footnote explains that, under the Amended and Restated Certificate of Incorporation, the reporting person’s Class B shares automatically convert into Class A shares on a one-for-one basis in substantially equal tranches on March 28, 2026 and September 27, 2026.

How many GRDN shares were involved in the derivative exercise?

The Form 4 shows a derivative exercise involving 1,298,826 underlying shares of Class A common stock tied to Class B common stock. These 1,298,826 Class B shares converted into an equal number of Class A shares at a stated price of $0.00 per share.